Huiping Lu

Prof. Huiping Lu

Department of Pharmacy, Shanghai Pudong Hospital

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
LZLaiyin Zhang
Laiyin Zhang
SHShuangxing Hou
Shuangxing Hou
BLBo Li
Bo Li
JPJianjian Pan
Jianjian Pan
LJLiping Jiang
Liping Jiang
HLHuiping Lu
Huiping Lu
Background: Betulinic acid (BA) is a complex lupane triterpenoid with unique antineoplastic activity. However, its antiproliferative activity is far from satisfaction. In order to improve its anticancer efficacy, betulinic acid was conjugated with a nitric oxide (NO)-releasing moiety to get a novel hybrid, BA-78. Methods: The antiproliferative activity of BA-78 against 6 cell lines and the ability of releasing nitric oxide were determined. The pro-apoptosis mechanism of BA-78 was investigated as well. Results: BA-78 exhibited time-dependent release of NO, and it displayed higher antiproliferative potential than BA through increasing apoptosis and inducing cell cycle arrest at G1 phase. Western blotting results showed that BA-78 increased the expression of Bax, Bid, Bad and cytochrome C and reduced the level of anti-apoptosis proteins including Bcl-2 and Bcl-xl. Conclusion: Our study revealed that novel compound BA-78, possessing betulinic acid and nitric oxide (NO)-releasing moiety, could be developed as an antitumor agent.

1 March 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SLShanshan Luo
Shanshan Luo
XGXianfeng Gu
Xianfeng Gu
HLHuiping Lu
Huiping Lu
CLChunhua Liu
Chunhua Liu
YSYaqi Shen
Yaqi Shen
Yi Zhun ZhuYi Zhun Zhu
Yi Zhun Zhu